Zobrazeno 1 - 10
of 16
pro vyhledávání: '"Supriya K. Jain"'
Autor:
Daniel N. Cagney, Shane Mesko, Diana D. Shi, Emil Lou, John Bryant, Supriya K. Jain, Hany Soliman, Arjun Sahgal, John P. Kirkpatrick, Eric Nesbit, Kristin A. Plichta, Cheng-Chia Wu, Steve Braunstein, Ashlyn S. Everett, Laurie E. Gaspar, Ryan Shanley, Drexell Hunter Boggs, Laura Masucci, Yi An, Jessica W. Lee, Ayal A. Aizer, Jing Li, William Sperduto, Paul D. Brown, Minesh P. Mehta, William G. Breen, Tim J. Kruser, Toshimichi Nakano, Hidefumi Aoyama, Veronica Chiang, Jill Remick, Paul W. Sperduto, John M. Buatti, Nan Lin, Tony J. C. Wang, Michael D. Chuong, Jason Chan, David Roberge, Helen A. Shih
Publikováno v:
J Clin Oncol
Journal of clinical oncology : official journal of the American Society of Clinical Oncology, vol 38, iss 32
Journal of clinical oncology : official journal of the American Society of Clinical Oncology, vol 38, iss 32
PURPOSE Conventional wisdom has rendered patients with brain metastases ineligible for clinical trials for fear that poor survival could mask the benefit of otherwise promising treatments. Our group previously published the diagnosis-specific Graded
Autor:
Ashlyn S. Everett, Emil Lou, Drexell Hunter Boggs, Helen A. Shih, Jessica W. Lee, Laura Masucci, Diana D. Shi, Jason Chan, Paul W. Sperduto, Laurie E. Gaspar, Paul D. Brown, Minesh P. Mehta, Jing Li, William Sperduto, Jill Remick, David Roberge, John M. Buatti, Nan Lin, Shane Mesko, Ryan Shanley, Kristin A. Plichta, Tony J. C. Wang, William G. Breen, John P. Kirkpatrick, Arjun Sahgal, Toshimichi Nakano, Ayal A. Aizer, James B. Yu, Michael D. Chuong, Supriya K. Jain, Hany Soliman, Veronica Chiang, John Bryant, Daniel N. Cagney, Hidefumi Aoyama, Cheng-Chia Wu, Tim J. Kruser, Steve Braunstein, Eric Nesbit
Publikováno v:
Int J Radiat Oncol Biol Phys
International journal of radiation oncology, biology, physics, vol 107, iss 2
International journal of radiation oncology, biology, physics, vol 107, iss 2
PurposeBrain metastases are a common sequelae of breast cancer. Survival varies widely based on diagnosis-specific prognostic factors (PF). We previously published a prognostic index (Graded Prognostic Assessment [GPA]) for patients with breast cance
Autor:
David Roberge, Jing Li, Steve Braunstein, Drexell Hunter Boggs, Laurie E. Gaspar, Emil Lou, Supriya K. Jain, Jessica W. Lee, Hany Soliman, Laura Masucci, Jill Remick, Arjun Sahgal, John P. Kirkpatrick, William Sperduto, William G. Breen, Jason Chan, Toshimichi Nakano, Diana D. Shi, Paul D. Brown, James B. Yu, Minesh P. Mehta, Helen A. Shih, Veronica Chiang, Paul W. Sperduto, John M. Buatti, Daniel N. Cagney, Kristin A. Plichta, Nan Lin, Michael D. Chuong, Tim J. Kruser, Eric Nesbit, Ashlyn S. Everett, Ryan Shanley, Shane Mesko, Cheng-Chia Wu, Ayal A. Aizer, Hidefumi Aoyama, John Bryant, Tony J. C. Wang
Publikováno v:
Neuro Oncol
Neuro-oncology, vol 22, iss 9
Neuro-oncology, vol 22, iss 9
Background Breast cancer treatment is based on estrogen receptors (ERs), progesterone receptors (PRs), and human epidermal growth factor receptor 2 (HER2). At the time of metastasis, receptor status can be discordant from that at initial diagnosis. T
Autor:
Lisa J. Wingrove, Megan D. Marsh, Supriya K. Jain, Laura Melton, Karyn A. Goodman, Tracey E. Schefter, S. Lindsey Davis, William T. Purcell, Michelle Bunch, Lindel C. Dewberry, Martin D. McCarter, Ashley E. Glode, Stephen Leong
Publikováno v:
Journal of the National Comprehensive Cancer Network. 17:QIM19-130
Background: At our institution, the standard treatment recommendation for esophageal cancer patients with stage IB–IIIB disease is for neoadjuvant chemoradiation per the CROSS regimen prior to surgery. This regimen can be difficult for patients to
Autor:
Karyn A. Goodman, Supriya K. Jain
Publikováno v:
Current Treatment Options in Oncology. 19
Assessing the quality of health care delivered is a priority across medical specialties, but it is particularly critical for radiation oncology, a field with rapid introduction of new technologies and treatment paradigms. Deviation from acceptable st
Autor:
Natalie A. Lockney, Penny Fang, D.J. Tandberg, J. Li, Jessica Parkhurst, Hirotake Saito, Michael D. Chuong, Laura Masucci, Cheng-Chia Wu, Diana D. Shi, Paul W. Sperduto, Daniel N. Cagney, Brent D. Cameron, Sten Myrehaug, Supriya K. Jain, Paul D. Brown, Minesh P. Mehta, William G. Breen, J.K. Molitoris, Ryan Shanley
Publikováno v:
International Journal of Radiation Oncology*Biology*Physics. 102:e314-e315
Autor:
Supriya K. Jain, Karyn A. Goodman
Publikováno v:
Handbook of Image-Guided Brachytherapy ISBN: 9783319448251
High-dose rate (HDR) brachytherapy can play an important role in the management of patients with gastrointestinal tumors, in particular those with rectal and anal cancers. Endorectal/endoanal brachytherapy is a safe, effective, and well-tolerated opt
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::8192b67e54ff163cb78c141cc0a22848
https://doi.org/10.1007/978-3-319-44827-5_11
https://doi.org/10.1007/978-3-319-44827-5_11
Autor:
Karyn A. Goodman, Supriya K. Jain
Publikováno v:
Handbook of Image-Guided Brachytherapy ISBN: 9783319448251
High-dose rate (HDR) endoluminal brachytherapy is a safe, effective and well-tolerated option for the treatment of patients with medically inoperable primary and recurrent esophageal tumors. Optimal endoluminal esophageal HDR technique uses a large d
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::d9f3746b51e378ad705b6fdf163c391c
https://doi.org/10.1007/978-3-319-44827-5_10
https://doi.org/10.1007/978-3-319-44827-5_10
Publikováno v:
International Journal of Radiation Oncology*Biology*Physics. 96:S173-S174
Publikováno v:
American journal of clinical dermatology. 14(6)
Lentigo maligna is a melanocytic neoplasm, often regarded as ‘melanoma in situ,’ which may progress to lentigo maligna melanoma. Lentigo maligna clinically presents as a pigmented, asymmetric macule that originates on the head and neck and spread